J&J | Frais De Vente Et D'Administration



Selling And Administration Expenses Changement Date
AbbVie USD 3.86B 306M 2024-12
Abbott USD 2.91B 21M 2024-12
Amgen USD 1.88B 253M 2024-12
AstraZeneca USD 5.55B 307M 2024-12
Baxter International USD 615M 16M 2024-12
Bayer EUR 4.34B 610M 2024-12
Becton, Dickinson and Co. USD 1.32B 62M 2024-12
Biogen USD 677.3M 99.6M 2024-12
Boston Scientific USD 1.61B 50M 2024-12
Bristol-Myers Squibb USD 2.1B 129M 2024-12
CONMED USD 123.97M 33.04M 2024-12
Cooper Companies USD 387.9M 3.5M 2025-01
Dexcom USD 327.4M 21M 2024-12
Edwards Lifesciences USD 491.9M 70.5M 2024-12
Eli Lilly USD 2.42B 324.7M 2024-12
Gilead Sciences USD 1.86B 451M 2024-12
GlaxoSmithKline GBP 2.66B 1.14B 2024-12
Globus Medical USD 253.48M 12.74M 2024-12
Hologic USD 265M 15.8M 2024-12
Indivior 133M 11M 2024-09
Insulet USD 261M 26.9M 2024-12
Integra LifeSciences USD 169.62M 5.48M 2024-12
Intuitive Surgical USD 612.6M 102M 2024-12
J&J USD 6.45B 975M 2024-12
Medtronic USD 2.72B 34M 2025-01
Merck USD 2.85B 148M 2024-12
Merit Medical Systems USD 102.57M 2.93M 2024-12
Novartis USD 3.5B 368M 2024-12
Pfizer USD 4.27B 1.06B 2024-12
Regeneron Pharmaceuticals USD 792.2M 77.8M 2024-12
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.68B 26M 2024-09
Stryker USD 2.03B 229M 2024-12
Tandem Diabetes Care USD 105.84M 6.2M 2024-12
Teva Pharmaceutical Industries USD 952M 28M 2024-12
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12
Zimmer Biomet Holdings USD 724.7M 18.8M 2024-12
Zoetis USD 625M 60M 2024-12



J&J Frais De Vente Et D'Administration - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.